La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (Istex)

Index « Titre (en) » - entrée « administration »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
administered < administration < administrative  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000360 (2011) Daryl J. Fediuk [Canada] ; Tao Wang [Canada] ; Yufei Chen [Canada] ; Fiona E. Parkinson [Canada] ; Michael P. Namaka [Canada] ; Keith J. Simons [Canada] ; Frank J. Burczynski [Canada] ; Xiaochen Gu [Canada]Tissue disposition of the insect repellent DEET and the sunscreen oxybenzone following intravenous and topical administration in rats
000763 (2009) Mohamed A. Shaker [Canada] ; Husam M. Younes [Canada, Qatar]Interleukin‐2: Evaluation of routes of administration and current delivery systems in cancer therapy
000884 (2008) Joohyung Lee [Canada, Australie] ; Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Naomi Visanji [Canada] ; Jonathan M. Brotchie [Canada]Receptor‐activity modifying protein 1 expression is increased in the striatum following repeated L‐DOPA administration in a 6‐hydroxydopamine lesioned rat model of Parkinson's disease
000945 (2008) Darcy Litteljohn [Canada] ; Emily N. Mangano [Canada] ; Shawn Hayley [Canada]Cyclooxygenase‐2 deficiency modifies the neurochemical effects, motor impairment and co‐morbid anxiety provoked by paraquat administration in mice
000950 (2008) C. Delguste [Belgique] ; H. Amory [Belgique] ; J. Guyonnet [France] ; D. Thibaud [France] ; P. Garnero [France] ; J. Detilleux [Belgique] ; O. M. Lepage [France] ; M. Doucet [Canada]Comparative pharmacokinetics of two intravenous administration regimens of tiludronate in healthy adult horses and effects on the bone resorption marker CTX‐1
000E41 (2003) Patrick L. Mcgeer [Canada] ; Claudia Schwab ; Andre Parent [Canada] ; Doris DoudetPresence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administration
001152 (2000) Marise B. Parent [Canada] ; Marie K. Habib [Canada] ; Glen B. Baker [Canada]Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine
001380 (1999) Line Ste-Marie [Canada] ; Luc Vachon [Canada] ; Chantal Bémeur [Canada] ; Jean Lambert [Canada] ; Jane Montgomery [Canada]Local striatal infusion of MPP+ does not result in increased hydroxylation after systemic administration of 4-hydroxybenzoate
001426 (1999) R. L. Sherry [Canada] ; R. T. Coutts [Canada] ; G. B. Baker [Canada]4‐fluorotranylcypromine, a novel monoamine oxidase inhibitor: Neurochemical effects in rat brain after short‐ and long‐term administration
001689 (1997) Verner J. Knott [Canada] ; Anne Harr [Canada] ; V. Ilivitsky [Canada]EEG correlates of acute nicotinic and muscarinic cholinergic blockade: separate and combined administration of mecamylamine and scopolamine in normal human subjects
001D27 (1993) M. Guttman [Canada] ; G. Léger [Canada] ; A. Reches [Israël] ; A. Evans [Canada] ; H. Kuwabara [Canada] ; J. M. Cedarbaum [États-Unis] ; J. M. Gjedde [Canada]Administration of the new COMT inhibitor OR‐611 increases striatal uptake of fluorodopa
001E67 (1992) Mark Guttman [Canada] ; Gabriel Léger [Canada] ; Jesse M. Cedarbaum [États-Unis] ; Avinoam Reches [Israël] ; William Woodward [États-Unis] ; Alan Evans [Canada] ; Mirko Diksic [Canada] ; Mirko Gjedde [Canada]3‐O‐methyldopa administration does not alter fluorodopa transport into the brain
002174 (1989) Nguyen T. Buu [Canada]Vesicular accumulation of dopamine following L-DOPA administration
002371 (1987) Thomas L. Perry [Canada] ; Voon Wee Yong [Canada] ; William J. Godolphin [Canada] ; Michelle Sutter [Canada] ; Shirley Hansen [Canada] ; Stephen J. Kish [Canada] ; James G. Foulks [Canada] ; Masatoshi Ito [Canada]Inability to produce a model of dialysis encephalopathy in the rat by aluminum administration
002763 (1981) S. R. Philips [Canada]Amphetamine, p‐hydroxyamphetamine and β‐phenethylamine in mouse brain and urine after (−)‐ and (+)‐deprenyl administration
002961 (1974) Andrée G. Roberge [Canada] ; L. J. Poirier [Canada]Brain DOPA/5-HTP decar☐ylase activity after the chronic administration ofl-DOPA or 5-hydroxyl-l-tryptophan in normal and lesioned cats

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "administration" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "administration" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    administration
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022